OABI Q4 2022 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$231M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$35M+131.3% YoY

Gross Profit

$32M90.7% margin

Operating Income

$9M25.3% margin

Net Income

$7M19.3% margin

EPS (Diluted)

$0.07

QoQ Revenue Growth

+411.5%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$20M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$421M

Total Liabilities

$80M

Stockholders' Equity

$341M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$15M	+131.3%
Gross Profit	$32M	$12M	+166.1%
Operating Income	$9M	-$3M	+369.6%
Net Income	$7M	-$3M	+322.0%